J. Bryan Iorgulescu

7.4k total citations · 1 hit paper
71 papers, 2.4k citations indexed

About

J. Bryan Iorgulescu is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, J. Bryan Iorgulescu has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 22 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in J. Bryan Iorgulescu's work include Glioma Diagnosis and Treatment (26 papers), Brain Metastases and Treatment (15 papers) and Meningioma and schwannoma management (15 papers). J. Bryan Iorgulescu is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Brain Metastases and Treatment (15 papers) and Meningioma and schwannoma management (15 papers). J. Bryan Iorgulescu collaborates with scholars based in United States, Australia and Netherlands. J. Bryan Iorgulescu's co-authors include Yoshiya Yamada, Mark H. Bilsky, David A. Braun, David A. Reardon, Timothy R. Smith, Derin B. Keskin, Ilya Laufer, Eric Lis, Talia Chapman and Kenneth J. Livak and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

J. Bryan Iorgulescu

69 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients

2013 341 citations J. Bryan Iorgulescu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Bryan Iorgulescu United States	28	860	582	522	500	491	71	2.4k
Ingfrid S. Haldorsen Norway	33	895 1.0×	436 0.7×	561 1.1×	435 0.9×	308 0.6×	131	3.5k
Michel Fabbro France	34	522 0.6×	778 1.3×	658 1.3×	407 0.8×	343 0.7×	187	3.1k
O. Raffel Australia	31	889 1.0×	454 0.8×	1.1k 2.2×	249 0.5×	251 0.5×	103	3.2k
Frank Hartmann Germany	25	639 0.7×	319 0.5×	561 1.1×	954 1.9×	288 0.6×	82	2.8k
P N Plowman United Kingdom	28	955 1.1×	396 0.7×	482 0.9×	306 0.6×	493 1.0×	94	2.8k
Sofia Haque United States	28	478 0.6×	391 0.7×	747 1.4×	221 0.4×	210 0.4×	95	2.5k
Gian Luigi Taddei Italy	26	544 0.6×	282 0.5×	595 1.1×	167 0.3×	347 0.7×	136	2.3k
Ho Jun Seol South Korea	28	670 0.8×	877 1.5×	621 1.2×	164 0.3×	936 1.9×	148	3.1k
Andreas Schirbel Germany	35	608 0.7×	216 0.4×	432 0.8×	263 0.5×	419 0.9×	106	3.1k
John T. Lucas United States	24	421 0.5×	514 0.9×	247 0.5×	335 0.7×	451 0.9×	123	2.2k

Countries citing papers authored by J. Bryan Iorgulescu

Since Specialization

Citations

This map shows the geographic impact of J. Bryan Iorgulescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bryan Iorgulescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bryan Iorgulescu more than expected).

Fields of papers citing papers by J. Bryan Iorgulescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bryan Iorgulescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bryan Iorgulescu. The network helps show where J. Bryan Iorgulescu may publish in the future.

Co-authorship network of co-authors of J. Bryan Iorgulescu

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bryan Iorgulescu. A scholar is included among the top collaborators of J. Bryan Iorgulescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bryan Iorgulescu. J. Bryan Iorgulescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wan, Qi, Ji‐Soo Kim, Jing Li, et al.. (2024). Auto-segmentation of Adult-Type Diffuse Gliomas: Comparison of Transfer Learning-Based Convolutional Neural Network Model vs. Radiologists. Journal of Imaging Informatics in Medicine. 37(4). 1401–1410. 4 indexed citations

Wen, Patrick Y., et al.. (2024). MGMT promoter methylation and survival following chemotherapy for WHO grade 4 IDH-mutant astrocytoma. Neuro-Oncology. 26(12). 2388–2390. 2 indexed citations

Price, Mackenzie, Katherine Ryan, Corey Neff, et al.. (2023). Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015–2019. Neuro-Oncology Practice. 11(1). 5–25. 17 indexed citations

Neff, Corey, Mackenzie Price, Gino Cioffi, et al.. (2023). The impact of the COVID-19 pandemic on treatment patterns in glioblastoma. Neuro-Oncology. 26(3). 581–583.

Toker, Joseph, J. Bryan Iorgulescu, Alexander Ling, et al.. (2023). Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors. Clinical Cancer Research. 29(12). 2226–2238. 27 indexed citations

Iorgulescu, J. Bryan, Asif Rashid, Priya Rao, et al.. (2023). Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular Testing. Current Oncology. 30(10). 9019–9027. 1 indexed citations

Ostrom, Quinn T., Gino Cioffi, Kristin Waite, et al.. (2022). National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States. Neuro-Oncology. 25(4). 799–807. 46 indexed citations

Lamba, Nayan, Malia McAvoy, Vasileios K. Kavouridis, et al.. (2022). Short-term outcomes associated with temozolomide or PCV chemotherapy for 1p/19q-codeleted WHO grade 3 oligodendrogliomas: A national evaluation. Neuro-Oncology Practice. 9(3). 201–207. 6 indexed citations

Papke, David, Neal I. Lindeman, Deborah Schrag, & J. Bryan Iorgulescu. (2022). Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Advanced Colorectal Cancer. Cancer Epidemiology Biomarkers & Prevention. 31(9). 1746–1751. 3 indexed citations

10.

Iorgulescu, J. Bryan, Corey Neff, Gino Cioffi, et al.. (2022). Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States. Neuro-Oncology. 24(11). 1989–2000. 49 indexed citations

11.

Neff, Corey, Gino Cioffi, Kristin Waite, et al.. (2022). Molecular marker testing and reporting completeness for adult-type diffuse gliomas in the United States. Neuro-Oncology Practice. 10(1). 24–33. 4 indexed citations

12.

Lamba, Nayan, Andrew Groves, Matthew Torre, Kee Kiat Yeo, & J. Bryan Iorgulescu. (2022). The epidemiology of primary and metastatic brain tumors in infancy through childhood. Journal of Neuro-Oncology. 156(2). 419–429. 17 indexed citations

13.

Backlund, Coralie M., Rebecca L. Holden, Kelly D. Moynihan, et al.. (2022). Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity. Proceedings of the National Academy of Sciences. 119(32). e2204078119–e2204078119. 36 indexed citations

14.

Lim-Fat, Mary Jane, Kun Song, J. Bryan Iorgulescu, et al.. (2021). Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma. Journal of Neuro-Oncology. 152(3). 515–522. 18 indexed citations

15.

Gutierrez, Catherine, et al.. (2021). Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the 2017 World Health Organization classification. Pituitary. 25(1). 201–209. 18 indexed citations

16.

Gohil, Satyen H., J. Bryan Iorgulescu, David A. Braun, Derin B. Keskin, & Kenneth J. Livak. (2020). Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy. Nature Reviews Clinical Oncology. 18(4). 244–256. 206 indexed citations

17.

Iorgulescu, J. Bryan, Maya Harary, Cheryl K. Zogg, et al.. (2018). Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort. Cancer Immunology Research. 6(9). 1039–1045. 56 indexed citations

18.

Sanders, Mary Ann, Stephanie M. Wong, J. Bryan Iorgulescu, & Susan C. Lester. (2018). Changes and Clarifications in the Eighth Edition of the AJCC Cancer Staging System for Breast Cancer. 23(3). 113–117. 2 indexed citations

19.

Karhade, Aditya V., Saksham Gupta, David J. Coté, et al.. (2016). Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis. Journal of Neuro-Oncology. 131(1). 59–67. 38 indexed citations

20.

Shah, Ashish H., Karthik Madhavan, Deborah O. Heros, et al.. (2011). The management of incidental low-grade gliomas using magnetic resonance imaging: systematic review and optimal treatment paradigm. Neurosurgical FOCUS. 31(6). E12–E12. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact